TY - JOUR
T1 - Comparison between traditional and guide-catheter extension reverse controlled antegrade dissection and retrograde tracking
T2 - Insights from the PROGRESS-CTO registry
AU - Xenogiannis, Iosif
AU - Karmpaliotis, Dimitri
AU - Alaswad, Khaldoon
AU - Jaffer, Farouc A.
AU - Yeh, Robert W.
AU - Patel, Mitul
AU - Mahmud, Ehtisham
AU - Choi, James W.
AU - Nicholas Burke, M.
AU - Doing, Anthony H.
AU - Dattilo, Phil
AU - Toma, Catalin
AU - Conrad Smith, A. J.
AU - Uretsky, Barry
AU - Krestyaninov, Oleg
AU - Khelimskii, Dmitrii
AU - Holper, Elizabeth
AU - Potluri, Srinivasa
AU - Michael Wyman, R.
AU - Kandzari, David E.
AU - Garcia, Santiago
AU - Koutouzis, Michalis
AU - Tsiafoutis, Ioannis
AU - Jaber, Wissam
AU - Samady, Habib
AU - Moses, Jeffrey W.
AU - Lembo, Nicholas J.
AU - Parikh, Manish
AU - Kirtane, Ajay J.
AU - Ali, Ziad A.
AU - Doshi, Darshan
AU - Tajti, Peter
AU - Rangan, Bavana Venkata
AU - Abdullah, Shuaib
AU - Banerjee, Subhash
AU - Brilakis, Emmanouil S.
N1 - Funding Information:
J Am Heart Assoc. 2016;5. mens, Regeneron, and Osprey; shareholderin MHI Ventures; Board ofTrustees er, GE Healthcare, and Medtronic; research support from Boston Scientific, Sie-
Funding Information:
2016;9:1-9. ic and St. Jude Medical. DrRangan reports research grants from InfraReDx and ship/principal in Shockwave Medical and VitaBx; research grants from Medtron-
Funding Information:
12. Matsuno S, Tsuchikane E, Harding SA, et al. Overview and proposed Funding: 9The Progress CTO registryhas received support from the Abbott North-
Funding Information:
16. Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire Vascular,and Asahi Intecc. Dr Kandzari reports research grants from Boston Asahi Intecc; consultant/advisoryboard income from Boston Scientific, Abbott
Funding Information:
chronic total occlusion of coronary arteries. Int Heart J. 2017;58:351-Abbott Vascular, Boston Scientific, and Siemens; research grants from Canon, non-financial, forAbbott Laboratories. Dr Jaffer reports consultant income from
Publisher Copyright:
© 2019 HMP Communications. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Objectives. The most common re-entry technique during retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is reverse controlled antegrade and retrograde tracking (rCART). The use of guide-catheter extensions can facilitate rCART, but has received limited study. Methods. We compared the clinical and procedural characteristics and outcomes of traditional rCART vs guide-catheter extension rCART vs cases in which both techniques were used (combined rCART) in patients with successful retrograde CTO crossing in a contemporary multicenter CTO-PCI registry. Results. Between 2012 and 2018, rCART was used in 467 of 1336 retrograde CTO-PCI cases. Guide-catheter extension rCART was used in 60/467 cases (13%; use increased from 0% in 2012 to 26% in 2017). The traditional rCART group, guide-catheter extension rCART group, and combined rCART group had similar target lesion J-CTO scores (3.3 ± 1.1 vs 3.2 ± 1.2 vs 3.6 ± 0.8, respectively; P=.28), technical success rates (99% vs 100% vs 96.4%, respectively; P=.36), procedural success rates (93.2% vs 93.8% vs 96.3%, respectively; P=.82), and major in-hospital adverse cardiac event (MACE) rates (6.4% vs 9.4% vs 3.6%, respectively; P=.66). Total procedural time was longer in the combined rCART group (196 min [IQR, 146-256 min] vs 200 min [IQR, 164-293 min] vs 255 min [IQR, 195-280 min], respectively; P<.01), with a trend for lower patient air kerma radiation dose in the guide-catheter extension groups (4.11 Gray [IQR, 2.49-5.77 Gray] vs 3.19 Gray [IQR, 1.29-4.74 Gray] vs 3.47 Gray [IQR, 2.89-5.56 Gray]; P=.07). Conclusions. Guide-catheter extension rCART is increasingly being used for retrograde CTO crossing and is associated with similar success and MACE rates as traditional rCART.
AB - Objectives. The most common re-entry technique during retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is reverse controlled antegrade and retrograde tracking (rCART). The use of guide-catheter extensions can facilitate rCART, but has received limited study. Methods. We compared the clinical and procedural characteristics and outcomes of traditional rCART vs guide-catheter extension rCART vs cases in which both techniques were used (combined rCART) in patients with successful retrograde CTO crossing in a contemporary multicenter CTO-PCI registry. Results. Between 2012 and 2018, rCART was used in 467 of 1336 retrograde CTO-PCI cases. Guide-catheter extension rCART was used in 60/467 cases (13%; use increased from 0% in 2012 to 26% in 2017). The traditional rCART group, guide-catheter extension rCART group, and combined rCART group had similar target lesion J-CTO scores (3.3 ± 1.1 vs 3.2 ± 1.2 vs 3.6 ± 0.8, respectively; P=.28), technical success rates (99% vs 100% vs 96.4%, respectively; P=.36), procedural success rates (93.2% vs 93.8% vs 96.3%, respectively; P=.82), and major in-hospital adverse cardiac event (MACE) rates (6.4% vs 9.4% vs 3.6%, respectively; P=.66). Total procedural time was longer in the combined rCART group (196 min [IQR, 146-256 min] vs 200 min [IQR, 164-293 min] vs 255 min [IQR, 195-280 min], respectively; P<.01), with a trend for lower patient air kerma radiation dose in the guide-catheter extension groups (4.11 Gray [IQR, 2.49-5.77 Gray] vs 3.19 Gray [IQR, 1.29-4.74 Gray] vs 3.47 Gray [IQR, 2.89-5.56 Gray]; P=.07). Conclusions. Guide-catheter extension rCART is increasingly being used for retrograde CTO crossing and is associated with similar success and MACE rates as traditional rCART.
KW - Chronic total occlusion
KW - Guide-catheter extension Fo
KW - Percutaneous coronary intervention
KW - Retrograde approach
KW - Reverse controlled antegrade and retrograde tracking
UR - http://www.scopus.com/inward/record.url?scp=85059497587&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059497587&partnerID=8YFLogxK
M3 - Article
C2 - 30418166
AN - SCOPUS:85059497587
SN - 1042-3931
VL - 31
SP - 27
EP - 34
JO - Journal of Invasive Cardiology
JF - Journal of Invasive Cardiology
IS - 1
ER -